Interestingly, HDL from stages III and IV grouped BC differed in its proteomics in comparison to stages I and II: alpha2-macroglobulin (A2M) and soluble tetranectin (CLEC3B) were reduced, and HPR, LCAT, SAA1, and IGHM were increased. The gene discussed is CLEC3B; the disease is breast cancer.